Midgard Science
R

Recipharm

Kayserberg, France recipharm.com

From their website, Nov 2026

Work here? Claim this listing

About

Recipharm is a global CDMO that develops and manufactures pharmaceutical products for small and large molecules, including oral solid doses, semi-solids, liquids, sterile products, controlled substances, vaccines, and advanced biologics. It serves pharmaceutical, biotech, veterinary, and other customers from a global network of facilities with local expertise.

Services

  • Oral solid dose development

    Develops oral solid dose products from early phases to manufacturing readiness using a Quality-by-Design approach.

  • Oral solid dose manufacturing

    Manufactures powders, granules, tablets, pellets, and hard capsules, including coated, uncoated, immediate-release, modified-release, and controlled-release forms.

  • Semi-solid formulation development and manufacturing

    Develops and manufactures topical and transdermal semi-solid products such as creams, gels, ointments, pastes, and suppositories.

  • Liquid formulation and manufacturing

    Develops and manufactures non-sterile and sterile liquid dosage forms including solutions, emulsions, suspensions, sprays, and aerosols.

  • Sterile vial filling

    Provides aseptic vial filling and terminal sterilisation for liquid-filled or lyophilised vial products.

  • Pre-filled syringe and cartridge filling

    Offers sterile filling of pre-filled syringes and pharmaceutical cartridges for parenteral products, including complex formulations.

  • Sterile lyophilisation

    Provides aseptic freeze-drying and lyophilisation cycle development and optimisation for sterile pharmaceutical products.

  • Vaccine manufacturing

    Supports vaccine manufacturing and aseptic fill-finish, including liquid and lyophilised mRNA COVID-19 vaccines.

  • Parenteral drug development

    Supports formulation development and sterility testing for injectable drugs, including solutions, suspensions, and lyophilised products.

  • Technology transfer

    Supports transfer of data, materials, knowledge, manufacturing, and quality control methods between sites or to third parties.

  • New product introduction (NPI)

    Manages the design and manufacturing introduction of new therapeutics and supports clinical and commercial product transfer.

  • Product development

    Provides formulation and process development using DoE and QbD for new chemical entities and generics.

  • ReciPredict

    Uses statistical modelling and simulation to support product development, tech transfer, and manufacturing decisions.

  • Controlled substance manufacturing

    Supports import, storage, manufacture, export, and analytical services for Schedule I-V controlled substances.

  • Animal health drug product manufacturing

    Manufactures veterinary dosage forms including liquids, semi-solids, sterile injectables, antibiotics, and anaesthetics.

  • Solid dosage form development and manufacturing

    Development and manufacturing solutions for solids, semi-solids, and liquid dosage forms.

  • Sterile fill & finish

    Sterile fill and finish development and manufacturing for biologics and small molecules.

  • Lyophilisation

    Aseptic lyophilisation and sterile freeze-drying services, including cycle development and scale-up.

  • Blow-fill-seal filling

    Aseptic unidose production using blow-fill-seal technology, from concept to commercial manufacturing.

  • Ampoule manufacturing

    Manufacturing services for ampoules as part of sterile delivery offerings.

  • OSD drug development

    Oral solid dose development services, including formulation and process development.

  • Analytical development

    Analytical method development and supporting development services.

  • Pharmaceutical analytical services

    Method development, validation, impurity identification, stability studies, and release testing.

  • Regulatory excellence

    Regulatory support services offered as part of additional services.

  • New product introduction

    Support for introducing new products and transferring processes into manufacturing.

  • Microbial & live biotherapeutic products

    Development and GMP manufacture of microbial and live biotherapeutic products.

  • Recombinant proteins

    Development and GMP manufacture of recombinant proteins.

  • Virus & viral vectors

    Development and GMP manufacture of viral vectors and virus-based products.

  • xRNA therapies

    Development and GMP manufacture of xRNA therapies.

Capabilities

Assays and studies
Lyophilization · Fill-finish · Analytical development · mRNA · Process development · Small molecules · Sterility testing · Endotoxin testing · Pharmacopoeia testing · Method development · Method validation · Stability testing
14 moreDissolution studies · Release analytics · Elemental impurities · Nitrosamine analytics · Container closure integrity testing · Viable particulate analysis · Non-viable particulate analysis · Extractables and leachables · Impurity identification · Stability studies · Release testing · Pharmacopeial testing · Extractables and leachables (E&L) · Elemental impurities testing
Scale and capacity
16 facilities in 8 countries · Commercial-scale manufacturing · Clinical trial manufacturing · High-volume vaccines · Billions of doses of sterile products · Up to OEB 5 · 17 facilities · 8 countries · 4,500+ people · More than 250 ongoing stability studies concurrently
Therapeutic areas
Vaccines · Animal health · Biologics · Injectables · Ophthalmics · Pulmonary

Instruments and platforms

  • Relevant to not stated
  • Mass spectrometry
  • High-resolution mass spectrometry
  • Preparative HPLC
  • NMR

Modalities and species

Modalities
Small molecule · mRNA · Viral vector · Cell therapy · Recombinant protein · Vaccine · Plasmid DNA
Species and models
NCEs · Generics · Pharmaceuticals · Biotech products · Veterinary products · Schedule I-V controlled substances

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

    As listed: cGMP

  • ISO 14001Self-reported

Company

Type
CDMO
Founded
1995
Team
4,500+ people

Locations

Based in
Kayserberg, France
Serves
global, Europe, USA

Public records

Wikidata
Q7302454 source

Similar labs

Work here? Claim this listing